Clinical applications of MS-based protein quantification (Q38802991)

6 September 2017

Clinical applications of MS-based protein quantification (English)

1 reference

6 September 2017

Bassel Sabbagh

1

1 reference

6 September 2017

Sonani Mindt

series ordinal

2

1 reference

6 September 2017

Michael Neumaier

series ordinal

3

1 reference

6 September 2017

Peter Findeisen

series ordinal

4

1 reference

6 September 2017

11 March 2016

1 reference

Proteomics - Clinical Applications

6 September 2017

1 reference

6 September 2017

10

1 reference

6 September 2017

323-345

1 reference

6 September 2017

4

1 reference

A selected history and future of immunoassay development and applications in clinical chemistry

6 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Interferences in hormone immunoassays

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

The fundamental flaws of immunoassays and potential solutions using tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Impact of disease on interferences in blood bioanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Cross-reactivity in antibody microarrays and multiplexed sandwich assays: shedding light on the dark side of multiplexing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

An evaluation of commercial fluorescent bead-based luminex cytokine assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Developing clinically relevant biomarkers in inflammatory arthritis: A multiplatform approach for serum candidate protein discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

A fast and validated mass spectrometry method for the evaluation of human serum albumin structural modifications in the clinical field.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Multiplex assays for biomarker research and clinical application: translational science coming of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Mass spectrometry-based targeted quantitative proteomics: achieving sensitive and reproducible detection of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Mass spectrometry-based protein assays for in vitro diagnostic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

LC-MS/MS for protein and peptide quantification in clinical chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Advancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Targeted quantification of low ng/mL level proteins in human serum without immunoaffinity depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Multiple-reaction monitoring-mass spectrometric assays can accurately measure the relative protein abundance in complex mixtures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Large-Scale Interlaboratory Study to Develop, Analytically Validate and Apply Highly Multiplexed, Quantitative Peptide Assays to Measure Cancer-Relevant Proteins in Plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Interlaboratory reproducibility of selective reaction monitoring assays using multiple upfront analyte enrichment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Preanalytical impact of sample handling on proteome profiling experiments with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Degradation and Stabilization of Peptide Hormones in Human Blood Specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Evaluating the effects of preanalytical variables on the stability of the human plasma proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Inhibition of intrinsic proteolytic activities moderates preanalytical variability and instability of human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Intrinsic peptidase activity causes a sequential multi-step reaction (SMSR) in digestion of human plasma peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Standardized approach to proteome profiling of human serum based on magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Analytical and preanalytical biases in serum proteomic pattern analysis for breast cancer diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Evaluation of protease inhibitors containing tubes for MS-based plasma peptide profiling studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

The impact of biosampling procedures on molecular data interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

"The quest for biomarkers": are we on the right technical track?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Serum protein profiling by solid phase extraction and mass spectrometry: a future diagnostics tool?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Quantitative and sensitive protein detection strategies based on aptamers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Proteomic analysis of human blood serum using peptide library beads

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

A novel biomarker harvesting nanotechnology identifies Bak as a candidate melanoma biomarker in serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Immunoaffinity purification of peptide hormones prior to liquid chromatography-mass spectrometry in doping controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Coupling immunoaffinity techniques with MS for quantitative analysis of low-abundance protein biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Detection of oxidized and glycated proteins in clinical samples using mass spectrometry--a user's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Antibody-free, targeted mass-spectrometric approach for quantification of proteins at low picogram per milliliter levels in human plasma/serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Sample preparation strategies for targeted proteomics via proteotypic peptides in human blood using liquid chromatography tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Quantitative mass spectrometry measurements reveal stoichiometry of principal postsynaptic density proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Trypsin immobilization on hairy polymer chains hybrid magnetic nanoparticles for ultra fast, highly efficient proteome digestion, facile 18O labeling and absolute protein quantification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

CE-MS-based proteomics in biomarker discovery and clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Body fluid peptide and protein signatures in diabetic kidney diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Advances in MALDI mass spectrometry in clinical diagnostic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Quantification of intermediate-abundance proteins in serum by multiple reaction monitoring mass spectrometry in a single-quadrupole ion trap.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Recent advances in targeted proteomics for clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Mass spectrometry based targeted protein quantification: methods and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Simplified and efficient quantification of low-abundance proteins at very high multiplex via targeted mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Selected reaction monitoring applied to proteomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Rapid empirical discovery of optimal peptides for targeted proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Automated detection of inaccurate and imprecise transitions in peptide quantification by multiple reaction monitoring mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Selectivity of LC-MS/MS analysis: implication for proteomics experiments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

A database of mass spectrometric assays for the yeast proteome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

PeptideAtlas: a resource for target selection for emerging targeted proteomics workflows

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

PRIDE: a public repository of protein and peptide identifications for the proteomics community

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Open source system for analyzing, validating, and storing protein identification data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Skyline: an open source document editor for creating and analyzing targeted proteomics experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Panorama: a targeted proteomics knowledge base

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

mProphet: automated data processing and statistical validation for large-scale SRM experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

MaRiMba: a software application for spectral library-based MRM transition list assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

MRMaid-DB: a repository of published SRM transitions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Systematic evaluation of quantotypic peptides for targeted analysis of the human kinome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Constrained selected reaction monitoring: quantification of selected post-translational modifications and protein isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Statistical characterization of multiple-reaction monitoring mass spectrometry (MRM-MS) assays for quantitative proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

MSstats: an R package for statistical analysis of quantitative mass spectrometry-based proteomic experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Isotope coded protein label quantification of serum proteins--comparison with the label-free LC-MS and validation using the MRM approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Selected reaction monitoring (SRM) mass spectrometry without isotope labeling can be used for rapid protein quantification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Large-scale quantitative clinical proteomics by label-free liquid chromatography and mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

OpenMS - an open-source software framework for mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Census 2: isobaric labeling data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

SuperHirn - a novel tool for high resolution LC-MS-based peptide/protein profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Isotope dilution mass spectrometry for absolute quantification in proteomics: concepts and strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

The absolute quantification strategy: a general procedure for the quantification of proteins and post-translational modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Absolute quantification of protein and post-translational modification abundance with stable isotope-labeled synthetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Multiplexed absolute quantification in proteomics using artificial QCAT proteins of concatenated signature peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Accurate quantification of cardiovascular biomarkers in serum using Protein Standard Absolute Quantification (PSAQ™) and selected reaction monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Combination of improved (18)O incorporation and multiple reaction monitoring: a universal strategy for absolute quantitative verification of serum candidate biomarkers of liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

An integrated quantification method to increase the precision, robustness, and resolution of protein measurement in human plasma samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Precision of heavy-light peptide ratios measured by maldi-tof mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Ion suppression in mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Towards the development of an immuno MALDI (iMALDI) mass spectrometry assay for the diagnosis of hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Development and evaluation of an immuno-MALDI (iMALDI) assay for angiotensin I and the diagnosis of secondary hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

An automated assay for the clinical measurement of plasma renin activity by immuno-MALDI (iMALDI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Toward improved peptide feature detection in quantitative proteomics using stable isotope labeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

An assessment of current bioinformatic solutions for analyzing LC-MS data acquired by selected reaction monitoring technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Review of software tools for design and analysis of large scale MRM proteomic datasets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Targeted quantitative analysis of Streptococcus pyogenes virulence factors by multiple reaction monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Data processing methods and quality control strategies for label-free LC-MS protein quantification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Quantifying protein measurands by peptide measurements: where do errors arise?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Standardized protocols for quality control of MRM-based plasma proteomic workflows.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Demonstrating the feasibility of large-scale development of standardized assays to quantify human proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Interlaboratory evaluation of automated, multiplexed peptide immunoaffinity enrichment coupled to multiple reaction monitoring mass spectrometry for quantifying proteins in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

DIGESTIF: a universal quality standard for the control of bottom-up proteomics experiments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Implementation of statistical process control for proteomic experiments via LC MS/MS

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Qualis-SIS: automated standard curve generation and quality assessment for multiplexed targeted quantitative proteomic experiments with labeled standards

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Reference measurement procedure development for C-reactive protein in human serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Feasibility of standardization of serum C-peptide immunoassays with isotope-dilution liquid chromatography-tandem mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Traceability in laboratory medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Approved IFCC reference method for the measurement of HbA1c in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Quantitative insulin analysis using liquid chromatography-tandem mass spectrometry in a high-throughput clinical laboratory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

External Quality Assessment Scheme for reference laboratories - review of 8 years' experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Assessment of peptide chemical modifications on the development of an accurate and precise multiplex selected reaction monitoring assay for apolipoprotein e isoforms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Simultaneous quantitation and size characterization of apolipoprotein(a) by ultra-performance liquid chromatography/mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Lipoprotein(a) mass: a massively misunderstood metric

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Mass Spectrometry-Based Proteomic Study Makes High-Density Lipoprotein a Biomarker for Atherosclerotic Vascular Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Quantification of transferrin in human serum using both QconCAT and synthetic internal standards.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Measurement of thyroglobulin by liquid chromatography-tandem mass spectrometry in serum and plasma in the presence of antithyroglobulin autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Thyroglobulin (Tg) Testing Revisited: Tg Assays, TgAb Assays, and Correlation of Results With Clinical Outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Simultaneous phenotyping and quantification of α-1-antitrypsin by liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Predicting prostate cancer biochemical recurrence using a panel of serum proteomic biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Quantification of a proteotypic peptide from protein C inhibitor by liquid chromatography-free SISCAPA-MALDI mass spectrometry: application to identification of recurrence of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Transthyretin mass determination for detection of transthyretin familial amyloid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Rapid and specific detection of clinically significant haemoglobinopathies using electrospray mass spectrometry-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Quantification of serum 1-84 parathyroid hormone in patients with hyperparathyroidism by immunocapture in situ digestion liquid chromatography-tandem mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Selected reaction monitoring-mass spectrometric immunoassay responsive to parathyroid hormone and related variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Variation in parathyroid hormone immunoassay results--a critical governance issue in the management of chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Pilot study for the standardization of insulin immunoassays with isotope dilution liquid chromatography/tandem mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Mass spectrometric determination of insulins and their degradation products in sports drug testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Mass spectrometric immunoassay of intact insulin and related variants for population proteomics studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Simultaneous determination and validated quantification of human insulin and its synthetic analogues in human blood serum by immunoaffinity purification and liquid chromatography-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Quantitative analysis of erythropoietin in human plasma by tandem mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Quantification of recombinant human erythropoietin by amino acid analysis using isotope dilution liquid chromatography-tandem mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Simultaneous quantification and qualification of synacthen in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Quantification of growth hormone in serum by isotope dilution mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Targeted proteomics of low-level proteins in human plasma by LC/MSn: using human growth hormone as a model system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for use of tumor markers in clinical practice: quality requirements

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Clinical quantitation of prostate-specific antigen biomarker in the low nanogram/milliliter range by conventional bore liquid chromatography-tandem mass spectrometry (multiple reaction monitoring) coupling and correlation with ELISA tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Analysis of serum total and free PSA using immunoaffinity depletion coupled to SRM: correlation with clinical immunoassay tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Glycosylation of prostate specific antigen and its potential diagnostic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Differentiation of lethal and non lethal prostate cancer: PSA and PSA isoforms and kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Quantitative analysis of prostate specific antigen isoforms using immunoprecipitation and stable isotope labeling mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Absolute ProGRP quantification in a clinical relevant concentration range using LC-MS/MS and a comprehensive internal standard

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Identifying and validating biomarkers for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Characterization of cerebrospinal fluid aminoterminally truncated and oxidized amyloid-β peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Evaluation of the performance of novel Aβ isoforms as theragnostic markers in Alzheimer's disease: from the cell to the patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Round robin test on quantification of amyloid-β 1-42 in cerebrospinal fluid by mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Quantitative detection of amyloid-β peptides by mass spectrometry: state of the art and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Determination of beta-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Development and validation of dried matrix spot sampling for the quantitative determination of amyloid β peptides in cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Characterization of amyloid beta peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

A screening UHPLC-MS/MS method for the analysis of amyloid peptides in cerebrospinal fluid of preclinical species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Total ApoE and ApoE4 isoform assays in an Alzheimer's disease case-control study by targeted mass spectrometry (n=669): a pilot assay for methionine-containing proteotypic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Plasma Proteome Database as a resource for proteomics research: 2014 update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

A repository of assays to quantify 10,000 human proteins by SWATH-MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Clinical proteomics: A need to define the field and to begin to set adequate standards

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Multiplexed quantitation of endogenous proteins in dried blood spots by multiple reaction monitoring-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Using data-independent, high-resolution mass spectrometry in protein biomarker research: perspectives and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Towards clinical applications of selected reaction monitoring for plasma protein biomarker studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Quantitative proteomics in cardiovascular research: global and targeted strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Quantitative proteomics for identification of cancer biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Developing proteomic biomarkers for bladder cancer: towards clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Liquid chromatography with tandem mass spectrometry-based proteomic discovery in aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Quantitative proteomics for investigating psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Multiplex profiling of tumor-associated proteolytic activity in serum of colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

A sequence-specific exopeptidase activity test (SSEAT) for "functional" biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Endoprotease profiling with double-tagged peptide substrates: a new diagnostic approach in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Functional protease profiling with reporter peptides in serum specimens of colorectal cancer patients: demonstration of its routine diagnostic applicability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

The road from discovery to clinical diagnostics: lessons learned from the first FDA-cleared in vitro diagnostic multivariate index assay of proteomic biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Implementation of proteomic biomarkers: making it work

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Important options available--from start to finish--for translating proteomics results to clinical chemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Searching for evidence: a guide to finding the evidence in laboratory medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

A roadmap for successful applications of clinical proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

How good is the evidence base for test selection in clinical guidelines?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Critical review of laboratory investigations in clinical practice guidelines: proposals for the description of investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Quantitative Clinical Chemistry Proteomics (qCCP) using mass spectrometry: general characteristics and application

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Verification of in vitro medical diagnostics (IVD) metrological traceability: responsibilities and strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Workshop report: Crystal City V--quantitative bioanalytical method validation and implementation: the 2013 revised FDA guidance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Regulatory challenges for diagnostic development - a European perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

New pathway for qualification of novel methodologies in the European Medicines Agency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Liquid chromatography tandem mass spectrometry in the clinical laboratory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Quantitative variability of 342 plasma proteins in a human twin population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Protein biomarker discovery and validation: the long and uncertain path to clinical utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Impact of automation on mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Positional proteomics in the era of the human proteome project on the doorstep of precision medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Determination of Cystatin C in human serum by isotope dilution mass spectrometry using mass overlapping peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Quantification of SAA1 and SAA2 in lung cancer plasma using the isotype-specific PRM assays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

A liquid chromatography-tandem mass spectrometry-based targeted proteomics approach for the assessment of transferrin receptor levels in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Quantitative profiling of serum samples using TMT protein labelling, fractionation and LC-MS/MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

A quantitative investigation of fucosylated serum glycoproteins with application to esophageal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Development of a Targeted Urine Proteome Assay for kidney diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Protein deep sequencing applied to biobank samples from patients with pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Multiple reaction monitoring-based, multiplexed, absolute quantitation of 45 proteins in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Quantification of seven apolipoproteins in human plasma by proteotypic peptides using fast LC-MS/MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Absolute quantification of DcR3 and GDF15 from human serum by LC-ESI MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Cancer genetics-guided discovery of serum biomarker signatures for diagnosis and prognosis of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

In-depth proteomics of ovarian cancer ascites: combining shotgun proteomics and selected reaction monitoring mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

A targeted proteomics-based pipeline for verification of biomarkers in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Identification of a Three-Biomarker Panel in Urine for Early Detection of Pancreatic Adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Detecting monoclonal immunoglobulins in human serum using mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Targeted human cerebrospinal fluid proteomics for the validation of multiple Alzheimer's disease biomarker candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Identification and validation of novel CSF biomarkers for early stages of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

A database of reaction monitoring mass spectrometry assays for elucidating therapeutic response in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Reproducible quantification of cancer-associated proteins in body fluids using targeted proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Identification of a seven glycopeptide signature for malignant pleural mesothelioma in human serum by selected reaction monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Multiplex targeted proteomic assay for biomarker detection in plasma: a pancreatic cancer biomarker case study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Quantification of cardiovascular biomarkers in patient plasma by targeted mass spectrometry and stable isotope dilution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

The ABRF Proteomics Research Group Studies: Educational exercises for qualitative and quantitative proteomic analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Platform for Establishing Interlaboratory Reproducibility of Selected Reaction Monitoring-Based Mass Spectrometry Peptide Assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

An on-line assay for clinical detection of amyloidogenic transthyretin variants directly from serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

Assay of Plasma Insulin in Human Subjects by Immunological Methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPRCA.201500116

21 January 2018

Identifiers

DOI

10.1002/PRCA.201500116

1 reference

6 September 2017

1 reference